Form 4: VolitionRx CEO Cameron Reynolds Reports Stock Award Vesting and RSU Cancellation
SEC Form 4 Filing
Cameron John Reynolds, CEO of VolitionRx Ltd, reports the vesting of 29,500 restricted stock units (RSUs) and the cancellation of 38,350 RSUs due to unmet performance goals.
Summary
- Cameron John Reynolds, the President and CEO of VolitionRx Ltd, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
- On August 15, 2024, 29,500 restricted stock units (RSUs) vested due to the achievement of certain corporate performance goals.
- These RSUs are part of an award of 118,000 RSUs granted on September 28, 2023, under the company's 2015 Stock Incentive Plan.
- The vested RSUs are subject to a 3-year time-based vesting schedule, with installments vesting on September 28, 2024, 2025, and 2026.
- Upon vesting and settlement, Reynolds will receive common stock equal to the number of RSUs that have vested.
- Additionally, 38,350 RSUs were cancelled on August 15, 2024, because the performance goals associated with them were not met.
- Reynolds directly owns 1,874,350 shares of common stock.
- He also indirectly owns 1,007,718 shares through Concord International, Inc., where he is the majority shareholder, and 34,076 shares through his spouse.
Sentiment
Score: 6
Explanation: The sentiment is neutral. While some RSUs vested, indicating achievement of performance goals, others were cancelled due to unmet goals. This suggests a mixed performance.
Positives
- The vesting of RSUs indicates that certain corporate performance goals were achieved.
Negatives
- The cancellation of 38,350 RSUs suggests that some performance goals were not met.
Risks
- The future vesting of the remaining RSUs is contingent on continued time-based vesting.
Future Outlook
The remaining vested RSUs will continue to vest in installments on September 28, 2025, and September 28, 2026.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The vesting and cancellation of RSUs may have a minor impact on shareholder equity.
- The vesting of RSUs could be seen as a positive sign for employees, indicating that performance goals are being met.
Next Steps
- The vested RSUs will continue to vest in installments on September 28, 2025, and September 28, 2026.
Key Dates
| Date | Description |
|---|---|
| 09/28/2023 | Reporting person was awarded 118,000 restricted stock units (RSUs) under the Issuer's 2015 Stock Incentive Plan. |
| 12/31/2023 | Date prior to which certain corporate performance goals needed to be achieved for RSU vesting. |
| 01/2024 | Rights with respect to 50,150 RSUs subject to the award previously vested and remain subject to time-based vesting. |
| 06/30/2024 | Date prior to which certain corporate performance goals needed to be achieved for RSU vesting. |
| 08/15/2024 | Date of transaction: 29,500 RSUs vested and 38,350 RSUs were cancelled. |
| 08/16/2024 | Date of signature on the Form 4 filing. |
| 09/28/2024 | First installment of time-based vesting for vested RSUs (9,833 units). |
| 09/28/2025 | Second installment of time-based vesting for vested RSUs (9,833 units). |
| 09/28/2026 | Third installment of time-based vesting for vested RSUs (9,834 units). |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.